<?xml version="1.0" encoding="UTF-8"?>
<p id="p0515">In an interesting study two libraries of drugs were docked against Mpro using three of the most common docking programs. Only the molecules with high consensus among the different algorithms were considered new promising SARS-CoV-2 Mpro inhibitors. The predicted candidates were: perampanel, carprofen, celecoxib, alprazolam, trovafloxacin, sarafloxacin and ethyl biscoumacetate 
 <xref rid="b0710" ref-type="bibr">[142]</xref>.
</p>
